GSK3B and Alzheimer disease: Therefore, despite our focus on AD, this could be a physiological response to any situation of intracellular increase in tau transcription, especially in light of the recently described PrPC involvement in the post-transcriptional control of tau by alternative splicing through inhibition of GSK3β [63].